FIRST PATIENT WITH BASAL CELL CARCINOMA TREATED IN NEW FOCUSED ULTRASOUND STUDY
The dermatology departments at Bispebjerg and Roskilde Hospitals, University of Copenhagen, Denmark, initiate pioneering treatment of the world’s most common cancer with a new convenient, minimal-pain and easy-to-operate modality for skin oncology. Hoersholm, Denmark, April 19[th] 2022 - TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) for dermatology, today announced that the first patients with basal cell carcinoma have been treated in a new clinical study using its System ONE-M device. Basal Cell Carcinoma (BCC) is the most common cancer in